Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,438 shares, an increase of 130.9% from the April 30th total of 3,655 shares. Based on an average daily trading volume, of 8,905 shares, the short-interest ratio is presently 0.9 days.
Carl Zeiss Meditec Trading Up 0.9%
Shares of OTCMKTS:CZMWY traded up $0.27 during midday trading on Tuesday, reaching $30.40. 10,194 shares of the company’s stock traded hands, compared to its average volume of 5,227. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $72.57. The company has a fifty day simple moving average of $30.09 and a two-hundred day simple moving average of $36.94.
Wall Street Analysts Forecast Growth
Separately, Zacks Research downgraded shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Monday, May 25th. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Carl Zeiss Meditec currently has a consensus rating of “Hold”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- Credo Technologies Paved a Path to a $300 Price Point
- Eli Lilly Wins Back CVS Health, Reverting Novo’s Advantage
- How the Latest Federal Contract Boosts D-Wave’s Prospects
- Alphabet’s $80 Billion Offering: Worrisome Dilution or AI Confidence?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
